AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Each Capsule Contains: Pregabalin 75,0 Mg

9 registrations across 1 African market— 5 active

Markets with Each Capsule Contains: Pregabalin 75,0 Mg

Recent registrations

Brand / ProductMarketHolderStatusExpires
PREGABALIN 75 JUBILANT🇿🇦South AfricaJubilant Pharma SA (Pty) LtdactiveAug 2030
ALOND 75 mg🇿🇦South AfricaViatris South Africa (Pty) LtdactiveAug 2030
ZANERVA 75🇿🇦South AfricaForrester Pharma (Pty) LtdactiveFeb 2030
UBABAX 75🇿🇦South AfricaAdcock Ingram LimitedsuspendedOct 2025
PREGABALIN 75 mg ADCO🇿🇦South AfricaAdcock Ingram LimitedsuspendedOct 2025
PREGABALIN 75 SUN PHARMA🇿🇦South AfricaRanbaxy (SA) (Pty) LtdsuspendedJun 2025
PREGABALIN 75 SANDOZ🇿🇦South AfricaSandoz South Africa (Pty) LtdsuspendedSept 2024
GLOVIREG 75🇿🇦South AfricaMacleods Pharmaceuticals SA (Pty) LtdactiveJan 1900
PREGABALIN 75 mg VIATRIS🇿🇦South AfricaViatris South Africa (Pty) LtdactiveJan 1900

Each Capsule Contains: Pregabalin 75,0 Mg in Africa — Regulatory Overview

Each Capsule Contains: Pregabalin 75,0 Mg is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 9 registrations, 5 (56%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.